Dog /
FDA CVM · 2025 release 952 reports on file

Spaniel - Springer (unspecified) - FDA Adverse Event Profile

Adverse-event records for Spaniel - Springer (unspecified) (Dog) from the FDA Center for Veterinary Medicine.

Verify with FDA CVM →
Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 57 42.75 28.5 14.25 0 2018 2019 2020 2021 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Spaniel - Springer (unspecified) drawn from FDA CVM filings.

Data updated June 2026

The record at a glance

With 952 reports on file, Spaniel - Springer (unspecified) sits at #112 among dog breeds by volume; death-coded share is 5.0% (48 reports).

#112
most-reported dog breed
5.0%
death-coded report share
164
Vomiting - top reaction
6.2 yr
average age at report

Higher volume usually means a more popular breed, not a riskier one, compare against how common the breed is.

Total Reports

952

FDA CVM filings

Deaths Reported

48

of 952 reports

Death Rate

5.0%

death-coded share

Avg Age at Report

6.2 yr

21.1 kg avg weight

Death-Coded Outcome Share

Spaniel - Springer (unspecified) death-coded reports 5.0%
Cross-breed median

5.0% of 952 spaniel - springer (unspecified) reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 21.1 kg (46.5 lbs)

Top Reported Reactions

Vomiting 164
INEFFECTIVE, HEARTWORM LARVAE 62
Lack of efficacy - NOS 61
Lack of efficacy (ectoparasite) - flea 60
Emesis 59
Diarrhoea 57
Lack of efficacy (endoparasite) - hookworm 57
Lethargy (see also Central nervous system depression in 'Neurological') 55

Most Referenced Drugs

Milbemycin Oxime + Spinosad 199
Spinosad 76
Milbemycin Oxime + Praziquantel 76
Pyrantel Pamoate;Sarolaner 70
Ivermectin, Pyrantel 50
Oclacitinib Maleate 49
Carprofen 48
Moxidectin 43

Outcome Breakdown

Recovered/Normal
216 (31.7%)
Outcome Unknown
205 (30.1%)
Ongoing
196 (28.7%)
Died
27 (4.0%)
Euthanized
21 (3.1%)
Recovered with Sequela
17 (2.5%)

Gender Distribution

Female 499 (52.4%)
Male 441 (46.3%)
Unknown 11 (1.2%)
Mixed 1 (0.1%)

Reports by Year

Year Reports Trend
2010 137
2011 117
2012 63
2013 62
2014 56
2015 50
2016 66
2017 39
2018 32
2019 43
2020 45
2021 36
2022 54
2023 49
2024 57
2025 46

Spaniel - Springer (unspecified) Pet Health Insights

Spaniel - Springer (unspecified) accounts for 952 FDA adverse event reports, ranking #112 by volume among dog breeds, with 48 reports (5.0%) coded as a death outcome. Mean age at report: 6.2 years, average weight 21.1 kg (46.5 lbs).

Top reported signs: Vomiting (164), INEFFECTIVE, HEARTWORM LARVAE (62), Lack of efficacy - NOS (61). Most-referenced drug: Milbemycin Oxime + Spinosad (199 reports), followed by Spinosad (76) and Milbemycin Oxime + Praziquantel (76).

Outcome coding on 682 status-recorded reports is dominated by Recovered/Normal (31.7%). Annual submissions ranged 2,010-2,025 across 16 years on file.

Dog Breeds With a Similar Report Volume

Frequently Asked Questions

How many FDA adverse event reports involve Spaniel - Springer (unspecified)?
There are 952 adverse event reports involving Spaniel - Springer (unspecified) in the FDA database, with 48 reports involving death (5.0% death rate). Spaniel - Springer (unspecified) ranks #112 by report volume.
What are the most common adverse reactions reported for Spaniel - Springer (unspecified)?
The most commonly reported adverse reactions for Spaniel - Springer (unspecified) are Vomiting (164 reports), INEFFECTIVE, HEARTWORM LARVAE (62 reports), Lack of efficacy - NOS (61 reports), Lack of efficacy (ectoparasite) - flea (60 reports), Emesis (59 reports).
What drugs are most frequently associated with Spaniel - Springer (unspecified) adverse events?
The drugs most frequently referenced in Spaniel - Springer (unspecified) adverse event reports are Milbemycin Oxime + Spinosad (199 reports), Spinosad (76 reports), Milbemycin Oxime + Praziquantel (76 reports), Pyrantel Pamoate;Sarolaner (70 reports), Ivermectin, Pyrantel (50 reports).
What is the average age of Spaniel - Springer (unspecified) in adverse event reports?
The average age of Spaniel - Springer (unspecified) at the time of adverse event reports is 6.2 years, with an average weight of 21.1 kg (46.5 lbs).
Does a high number of adverse event reports mean Spaniel - Springer (unspecified) is unhealthy?
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Spaniel - Springer (unspecified) safety data come from?
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.